INM MEXC RealStocks
Own real INM shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-17 23:48:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
InMed Pharmaceuticals Inc. (INM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $15.00, with a market capitalization of $8.55M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.88 to $16.44. This page covers its latest market performance, valuation, price trends and company information.
$8.55M | |
$13.71 | |
$15.85 | |
$12.98 | |
$13.21 | |
26.63K | |
14.44K | |
-- | |
$16.44 | |
$2.88 | |
-- | |
-- |
InMed Pharmaceuticals Inc. (INM) is trading at $14.50 in after-hours trading as of 2026-11-07 00:31:00, down 3.33% ($0.50) from the regular-session close of $15.00.
After-hours trading shows how investors are pricing INM after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, InMed Pharmaceuticals Inc. (INM) moved from $8.13 to $15.00, representing a gain of 84.60% ($6.87).
The stock traded between $7.43 and $16.44 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 23.15 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 89.4%
INM is currently trading at $15.00, placing it 89.4% of the way from its 52-week low of $2.88 to its 52-week high of $16.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for InMed Pharmaceuticals Inc.
Stock Split | |
|---|---|
| Split Date | Nov 5, 2026 |
| Split Ratio | 1-for-10 |
Eligible investors can buy real shares of InMed Pharmaceuticals Inc. (INM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to INM, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between INM shares and USD.
INM Shares to USD
1.00 INM shares = 14.999 USD
Calculations are estimates based on the latest available price and are for reference only.